Lipid Nanoparticle Market Analysis, October 2022

Lots has been happening in the Lipid Nanoparticle Market. Here's the latest from October: 17 patent publications this month (40% of which mention mRNA or RNA), a licensing deal between Omega Therapeutics and Nitto Denko Corporation for Nitto Denko Corporation's LNP technology, published success of a synthetic vRNA/LNP platform, and more.

Check it out and be on the lookout for the November issue in the beginning of December.

Download a copy of the Market Analysis below.